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Summary
Beyond their role in cell metabolism, development, and
reproduction, hormones are also important modulators of
the immune system. In the context of inflammatory dis-
orders, systemic administration of pharmacological doses
of synthetic glucocorticoids (GCs) is widely used as an
anti-inflammatory treatment [1, 2]. However, not all actions
ofGCs are immunosuppressive, andmany studies have sug-
gested that physiological concentrations of GCs can have
immunoenhancing effects [3–7]. For a more comprehensive
understanding of how steroid hormones regulate immunity
and inflammation, a simple in vivo system is required. The
Drosophila embryo has recently emerged as a powerful
model system to study the recruitment of immune cells to
sterile wounds [8] and host-pathogen dynamics [9]. Here
we investigate the immune response of the fly embryo
to bacterial infections and find that the steroid hormone
20-hydroxyecdysone (20-HE) can regulate the quality of the
immune response and influence the resolution of infection
in Drosophila embryos.Results and Discussion
Drosophila Embryos Can Mount an Immune Response to
Bacterial Challenge
Using a previously established embryo microinjection assay
[9], we first sought to determine whether late-stageDrosophila
embryos are able to induce a humoral immune response after
septic injury. The humoral response to microbe infection in
Drosophila is largely mediated by two pathways: Imd and
Toll. Pathogen recognition is initiated by pattern recognition
receptors that bind conserved stereotypical, rather than
particular, molecular structures present in a wide spectrum
of microorganisms but absent in the host [10], such as pepti-
doglycan (PGN), which is a major constituent of the cell wall
of both Gram-negative and Gram-positive bacteria [11].
Drosophila senses mesodiaminopimelic acid (DAP)-type
PGN present in a single layer within the Gram-negative bac-
teria periplasmic space via two peptidoglycan recognition
proteins (PGRPs), the membrane-bound PGRP-LC and the
secreted and/or cytosolic PGRP-LE, activating the Imd
signaling pathway. Sensing of the Lys-type peptidoglycan
present on the surface of Gram-positive bacteria is mediated
by PGRP-SA, PGRP-SD, and Gram-negative binding protein
1 (GNBP1), which relay the signal to the Toll pathway [12]. A
subclass of Gram-positive bacteria including Bacillus species
and Listeria monocytogenes also produce DAP-type PGN,2Co-first author
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[12]. Activation of antimicrobial peptide (AMP) genes and
quantification of pathogen load are widely used in both larval
and adult fly models as readouts of the immune response.
As a proxy for AMP production, we monitored the expression
of a Drosocin-gfp (Drc-GFP) promoter fusion construct in
stage 15 embryos injected with either Escherichia coli
(E. coli) or Erwinia carotovora carotovora 15 (Ecc15) [13].
Infection with E. coli or Ecc15 initially induces Drc-GFP
transgene expression throughout the tracheal system as early
as 3 hr postinfection (hpi) (Figure 1A). This is followed by a later
expression in the epithelium at 6 hpi (Figures 1D and 1E). The
microinjection process itself had no effect onDrosocin expres-
sion (Figure 1C). To assess the early effects of septic injury on
stage 15 embryos in more detail, we analyzed the transcrip-
tional response of several AMP genes, including Cecropin
A1, Defensin, Diptericin, Drosocin, Drosomycin, and Metchni-
kowin, by real-time quantitative PCR (qPCR). Injection with
E. coli or Ecc15 induced the expression of all antimicrobial
peptide genes tested (Figures 1F–1J) except for the antifungal
peptide gene Drosomycin, which in turn was only upregulated
after infection withMicrococcus luteus (M. luteus) (Figure 1K).
To ascertain whether the differential response in the embryo
was mediated via the Toll and Imd signaling pathways, we
assessed Diptericin (Dpt) and Drosomycin (Drs) expression
in response to Ecc15 and M. luteus injection in embryos
mutant for either the Imd signaling component Relish (RelE20)
or the Toll signaling component modular serine protease
(modSP1). Dpt expression was significantly diminished in
RelE20 embryos after infection with Ecc15 in comparison to
wild-type levels (Figure 2A), demonstrating a clear requirement
for Imd signaling in the immune response to DAP-type PGN
stimulation at this early time in the infection. Moreover, this
effect on Dpt is specific to Ecc15 infection, as injection with
neither the carrier nor M. luteus seems to affect the levels of
Dpt transcript in RelE20 mutant embryos (Figure 2A). Similarly,
modSP1 embryos injected with M. luteus fail to upregulate
expression of Drs, confirming the importance of Toll signaling
in mounting an immune response to Lys-type PGN in the em-
bryo (Figure 2B).
The absence of Imd and Toll signaling was also shown to
impact the viability of stage 15 embryos after septic injury.
The survival of RelE20, modSP1, and persephone1 (psh1);
modSP1 double mutant embryos was monitored 24 hr after
injection with different microbial stimuli (Figure 2C). Neither
the damage caused by the injection process nor the infection
affected the survival of wild-type embryos. All mutant embryos
appear to survive infection with E. coli; however, injection with
M. luteus selectively and significantly reduced the survival of
modSP1 and psh1;modSP1 double mutant embryos, confirm-
ing that the Toll pathway is necessary for the resolution of
Gram-positive infections at this stage of Drosophila develop-
ment. Ecc15 infection decreased the viability not only of
RelE20 but also of psh1;modSP1 double mutant embryos,
despite the fact that modSP1 mutant embryos are still able
to induce similar levels of diptericin at the early stage of infec-
tion and are able to resist infection with Ecc15 (Figures 2A and
2C), highlighting the contribution of the Toll pathway in resis-
tance to Ecc15-induced damage at this stage of development.
Figure 1. Stage 15 Drosophila Embryos Are Able to Mount Immune Responses to Bacterial Challenge
(A–E) A stage 15 embryo expressing Drosocin-GFP stained with anti-GFP (Ai) and the tracheal-specific antibody 2A12 (Aii). The merge (Aiii) shows clear Drc
expression throughout the tracheal network 3 hpi with Ecc15. A live, untreated, Drc-GFP-expressing embryo (B) and a Drc-GFP-expressing embryo (C) 6 hpi
with PBS show no Drc expression, whereas injection with either E. coli (D) or Ecc15 (E) leads to robust expression in the embryonic epithelium (arrowheads).
Arrows show autofluorescence in the yolk. Scale bars represent 20 mm (A) and 50 mm (B–E).
(F–K) Real-time qPCR analysis of Drosocin (F), Cecropin A1 (G), Defensin (H), Diptericin (I), Metchnikowin (J), and Drosomycin (K) in stage 15 embryos
injected with endotoxin-free PBS or live bacterial cells of E. coli,M. luteus, and E. carotovora (Ecc15) for 2 hr. The expression of antimicrobial peptide genes
was normalized to the reference gene rp49 and then standardized to the expression level of nontreated samples. The mean of three independent biological
replicates is shown, and error bars represent the SD. *p < 0.05, **p < 0.01, and p*** < 0.001 as determined by one-way ANOVAwith an ad hoc Tukey’smultiple
comparison test. n = 200 embryos.
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naturally occurring polymorphisms in Toll pathway intra-
cellular signaling components, such as Cactus and Dif, are
necessary to contain a systemic infection with the Gram-negative pathogen Serratia marcescens [14]. Although this
mechanism is still obscure, several studies have proposed a
possible crosstalk between the proteolytic cascades that
regulate the Toll pathway and those regulating the
Figure 2. Stage 15 Drosophila Embryos Are Able to Effectively Distinguish between Different Types of Infection
(A) Real-time qPCR analysis of Diptericin expression in stage 15 embryos 2 hr after Ecc15 infection in the wild-type and Relish (RelAE20) andmodular serine
protease (modSP1) mutants shows a clear requirement for Imd signaling in the response to Ecc15.
(B) Real-time qPCR showing that the expression of Drosomycin in stage 15 embryos infected with M. luteus depends on the Toll signaling component
modSP1.
(C) Percentage survival 24 hpi of RelAE20,modSP1, and psh;modSP1 embryos infected with the Gram-positive bacteriaM. luteus, the Gram-negative bac-
teria Ecc15 and E. coli, and an Aspergillus fumigatus protease cocktail compared with PBS-injected wild-type embryos. *p < 0.05, **p < 0.01, and ****p <
0.001 as determined by two-way ANOVA followed by an ad hoc Tukey’s multiple comparison test. n = 100 embryos for all genotypes.
(D) Bacterial load in infected stage 15 embryos. Bacterial load is controlled in wild-type embryos, but not in RelAE20 or modSP1 embryos. Infections were
performed in groups of 25 embryos and reproduced in at least six independent experiments. ****p < 0.001 as determined by determined by two-way ANOVA
followed by an ad hoc Tukey’s multiple comparison test.
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Figure 3. Stage 11 Embryos Show Reduced Immune Competency in Response to Bacterial Invasion
(A) Stage 11 embryos expressing Drosocin-GFP fail to switch on Drosocin upon superficial injection with Ecc15 (compare to stage 15). This development of
immune competence coincides with a pulse of ecdysone in the embryo that peaks at approximately 8 hr after egg laying.
(B) Survival analysis upon septic injection with E. coli, Ecc15, andM. luteus in stage 15 and stage 11 wild-type embryos clearly shows that early embryos are
compromised in their survival after infection with all bacteria tested. Statistical significance was determined by multiple unpaired t tests (*p < 0.05, **p <
0.01). n = 100 embryos for all genotypes.
(C) Stage 11 and stage 15 embryos were injected with Ecc15, E. coli, orM. luteus, and colony-forming units were determined at 8 hpi. Bacterial load is signif-
icantly higher in infected stage 11 embryos. The significancewas assessed bymultiple unpaired t tests (p < 0.01). The infections were performed in groups of
25 embryos and reproduced in six independent experiments.
(D) Effect of bacterial infection upon survival of stage 15 ecdysone receptor mutant embryos shows that mutants have compromised survival at 24 hpi with
Ecc15. The survival of embryos expressing dominant-negative EcR-B1 receptor in hemocytes (srp>EcR-B1 DN) was not significantly different from that of
wild-type embryos, whereas expression of dominant-negative EcR-B1 receptor in the trachea using btl-Gal4 leads to a reduction in survival to levels
(legend continued on next page)
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modSP1 and psh1;modSP1 double mutant embryos were
also less fit compared to wild-type embryos after injection
with Aspergillus oryzae proteases. We then sought to deter-
mine the efficacy of the immune response upon different infec-
tions. RelE20 and modSP1 mutant embryos were infected with
E. coli, Ecc15, and M. luteus, and viable bacterial load was
measured by quantitative plating at 8 and 24 hr after infection
(Figure 2D). Higher bacterial loads were observed in mutant
embryos only at 24 hr after infection confirming the importance
of Imd and Toll pathways in controlling the infection. Taken
together, these results demonstrate that stage 15 embryos
are able to suppress infection between 8 and 24 hr after injec-
tion and that these responses are mediated via the well-char-
acterized Imd and Toll signaling pathways that have been
shown to play a crucial role in the systemic immune response
of Drosophila larvae and adults.
Early-Stage Embryos Have a Compromised Immune
Response
To assess whether embryos at other stages of embryogenesis
are able to control infection, we focused our analysis on the
AMP responses of embryos at stage 11 of development to
Gram-negative infection. In stark contrast to stage 15
embryos, stage 11 embryos fail to express Drosocin upon
infection with Ecc15 (Figure 3A). This finding initially seemed
at odds with previous studies that have shown yolk-specific
Cecropin expression to be activated upon PBS and bacterial
injections in early-stage embryos [19]. To investigate this
apparent discrepancy in more detail, we sought to determine
the potential contribution of the type of injection on early-stage
embryos. Using a Cecropin-LacZ fusion line [19], we injected
early-stage embryos with endotoxin-free PBS or Ecc15 either
deeply (causing damage to the yolk) or superficially (as all
other injections performed in this study). Consistent with
previous studies [19], induction of cecropin in the yolk was
clearly observed after deep injections, but no expression
was seen after superficial injections (Figure S1A available
online). Interestingly, the yolk-specific expression of Cecropin
was triggered after deep injections whether bacteria were
present or not. We also examined AMP gene induction in
early-stage embryos after deep injection, confirming the
induction of Cecropin under these conditions (Figure S1C).
However, we saw no change in the expression of Attacin A,
Diptericin, or Drosocin (Figures S1B, S1D, and S1E, respec-
tively) after injection. These results demonstrate that while
early embryos are unable to raise an immune response to
infection, the yolk appears primed to trigger robust Cecropin
expression in response to damage, reminiscent of the dam-
age-induced AMP response previously demonstrated in late-
stage embryos [8].
Stage 11 embryos were also not able to contain an infection,
as revealed by monitoring the bacterial load as early as 8 hpi
(Figure 3C) and their survival to the first-instar larval
stage postinfection with bacterial species considered to be
nonpathogenic in larvae and adults (Figure 3B). The inability
of stage 11 embryos to control infection could reflect either a
faster bacterial growth in younger embryos attributable to
ample nutrient availability or equally a difference in cellularobserved in EcRmutants. Statistical significance was determined by two-way
and ***p < 0.005). n = 100 embryos for all genotypes.
(E) Bacterial load is higher in infected stage 15 btl>EcR-B1 DN embryos than in
unpaired t tests (*p = 0.004).and humoral resistance mechanisms employed by embryos
at different developmental stages.
Ecdysone Mediates Immune Development in the Embryo
Several studies have suggested that 20-hydroxyecdysone
(20-HE) affects the innate immune response of Drosophila
[20–27]. These studies have shown that 20-HE enhances the
expression of AMP genes in infected cultured cell lines and
animals. The positive regulatory effects of 20-HE on the Imd
pathway have recently been shown to be mediated by at least
twomechanisms: one in which 20-HE regulates the expression
of the peptidoglycan receptor PGRP-LC, and a second PGRP-
LC-independent mechanism that regulates the expression of
specific AMPs, including Dpt, Drs, and Mtk, via the transcrip-
tion factors Broad complex (Br-C), Serpent (Srp), and Pannier
(Pnr) [24]. Pulses of 20-HE act as cues for initiating develop-
mental and physiological transitions [28], and one such pulse
occurs during embryogenesis after completion of gastrulation
and the formation of organ primordia at 6–10 hr of develop-
ment, with a peak at 8 hr (approximately stage 12 of embryo-
genesis) [29–31] (Figure 3A). Given the difference in immune
competence we observe between stage 11 and stage 15
embryos, we reasoned that the maturation of the immune
system might be dependent on this ecdysone pulse.
Responses to ecdysone are transduced by a heteromeric
nuclear receptor, consisting of the ecdysone receptor (EcR)
and the fly ortholog of the vertebrate retinoid X receptor
(RXR), Ultraspiracle (Usp) [32, 33]. To test whether ecdysone
was mediating the development of immune competence, we
analyzed the immune capability of embryos mutant for the
EcR receptor.
We first verified whether stage 15 embryos containing
mutations in EcR were viable. Noninfected stage 15 hetero-
zygous (EcRQ50st/CTG, EcRM55fs/CTG), homozygous
(EcRQ50st/EcRQ50st, EcRM55fs/EcRM55fs), and transhetero-
zygous (EcRQ50st/EcRM55fs) ecdysone receptor mutant em-
bryos were monitored for development to first-instar larvae.
EcRQ50st mutation affects expression of the EcR-B1 isoform,
whereas EcRM55fs mutation is in a common exon and conse-
quently affects all three EcR isoforms of the EcR protein
[34]. Heterozygous, transheterozygous, and homozygous
EcRQ50stmutant embryos did not show a significant difference
in viability in comparison to wild-type embryos (Figure 3D). In
contrast, EcRM55fs homozygous mutants were less fit, with
only a small percentage of themhatching into first-instar larvae
(data not shown). We then tested the susceptibility of stage 15
EcRQ50st homozygous and EcRQ50st/EcRM55fs transhetero-
zygous mutant embryos to Ecc15 infection. Survival of
EcRQ50st homozygous and EcRQ50st/EcRM55fs transhetero-
zygous mutant embryos was significantly compromised by
Ecc15 infection compared to wild-type survival at 24 hpi (Fig-
ure 3D), similar to the viability of embryos injected with Ecc15
at stage 11 of development (compare with Figure 3B). Further-
more, infection of stage 15 EcRQ50st/EcRM55fs transhetero-
zygous mutant embryos with Ecc15 failed to induce the
expression of three AMP genes: Cecropin, Defensin, and
Metchnikowin (Figure 4A).
The fat body is the Drosophila functional equivalent of the
mammalian liver and has been implicated as themajor immuneANOVA followed by Tukey’s multiple comparison test (*p < 0.05, **p < 0.01,
control embryos at 8 hpi. Statistical significance was determined bymultiple
Figure 4. Ecdysone Regulates Embryonic Immune Responses
(A) Real-time qPCR analysis of Cecropin A1, Defensin, and Metchnikowin expression in stage 15 wild-type and transheterozygous EcRQ50st/EcRM55fs
mutant embryos at 2 hpi with Ecc15. Graphs show a reduced expression of all three AMPs in themutant after infection. Gene expression levels were normal-
ized to rp49 levels and were then standardized to nontreated samples and presented as fold change. For each treatment, the values shown represent the
mean of three independent experiments. Error bars represent the SD. *p < 0.05, **p < 0.01, and ***p < 0.001 as determined by one-way ANOVAwith an ad hoc
Tukey’s multiple comparison test.
(B) Representative images of Drosocin-GFP-expressing stage 11 and stage 15 embryos 12 and 6 hpi, respectively, with Ecc15. Images show an apparent
lack of Drc-GFP expression in young embryos upon bacterial infection (Ecc15), which can be rescued upon coinjection with 25 mMecdysone (Ecc15+20HE).
Treatment with ecdysone in the absence of bacteria did not cause an upregulation of Drosocin (20-HE). Scale bars represent 50 mm.
(C) Real-time qPCR analysis of Drosocin expression in stage 11 embryos after treatment with 25 mM 20-HE. The graph shows that, consistent with Drc-GFP
data in (B), addition of ecdysone is able to rescue Drosocin expression in early embryos upon Ecc15 infection. Error bars represent the SD. *p < 0.05 as
determined by one-way ANOVA with an ad hoc Holm-Sidak’s multiple comparison test.
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into the hemolymph [12, 35]. Since the fat body only matures
at larval stages and given the fact that we do not observe
AMP production in the developing fat body in infected
embryos, we sought to determine where in the embryo the
ecdysone signal is required in controlling immune function.
Embryonic hemocytes are the Drosophila equivalent of the
vertebrate macrophage and have been shown to efficiently
clear bacteria at sites of infection in the embryo [9]. Recent
studies have shown a requirement for ecdysone signaling
within pupal hemocytes for their efficient clearance of some
bacteria [36]. To test whether the ecdysone signaling was
required in embryonic hemocytes, we expressed a domi-
nant-negative form of EcR-B1 in hemocytes under the control
of the hemocytes-specific promoter srp and followed the
survival of these embryos after Ecc15 infection. Expression
of EcR-B1 in hemocytes compromised the viability of em-
bryos; however, this effect was not statistically significant
compared to wild-type embryos (Figure 3D). While expressionof EcR-B1 in hemocytes had a minor effect, expression of the
same construct in the trachea severely compromised the
ability of the embryos to control the infection as early as
8 hpi (Figure 3 E) and contributed to significant killing at later
stages such that viability was reduced to the level seen in
EcR mutants (Figure 3D). These results show that it is within
the tracheal epithelium, the site where AMP production is first
observed after infection (Figure 1A), that ecdysone signaling is
required and highlights the importance of the tracheal epithe-
lium in the embryonic immune response to infection.
Our results demonstrate a clear requirement for ecdysone
signaling in mediating the development of the immune
response in embryos, but is ecdysone alone sufficient to
confer immune competence? To test this, we treated stage
11 embryos with ecdysone, infected them with Ecc15, and
monitored their ability to express the AMP Drosocin. Remark-
ably, we found that ecdysone-treated stage 11 embryos were
able to upregulate Drosocin to similar levels to infected stage
15 embryos (Figures 4B and 4C), demonstrating that edcysone
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further highlights the importance of this steroid hormone in
mediating the maturation of the immune system in the fly.
In this study, we have addressed the embryonic immune
response mechanism in the fly. Our results demonstrate that
the embryo uses the Imd and Toll signaling pathways to
mediate protective immune responses to bacterial infections.
We show that the developing barrier tracheal epithelium is
the primary embryonic tissue responding to infection and
demonstrate that the ecdysone pulse at stage 12 of embryo-
genesis is fundamental for the maturation of the immune
system of the embryo, with a precocious dose of the hormone
being sufficient to confer immune competence to early em-
bryos. Further studies using simple in vivo models such as
the Drosophila embryo are critical if we are to understand
more clearly the role of steroid hormone signaling in mediating
inflammation and immunity in vivo.Experimental Procedures
Fly Stocks
Drosophila stocks were maintained at 22C for all experiments. w;srp-
Gal4,UAS-GFP;crq-Gal4,UAS-GFP were used as wild-type flies. RelE20,
modSP1 psh1;;modSP1, EcRQ50st/CTG, EcRM55fs/CTG mutant fly lines and
the Drosocin-GFP and Cecropin-lacZ lines have been described previously
[14, 15, 19, 34, 37–40]. Expression studies with the GAL4/UAS system were
carried out using UAS-EcR-DN (UAS-EcR.B12DC655.W650A) [38].
A detailed description of the methods is included in the Supplemental
Experimental Procedures.Supplemental Information
Supplemental Information includes one figure and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2014.03.062.
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